Melanoma patients who are treated with new oral drugs inhibiting the BRAF gene are at increased risk for developing secondary skin cancers. A new study co-authored by Vanderbilt-Ingram Cancer Center investigators and researchers from 12 other cancer centers discovered clues that may explain what is triggering these secondary cancers. VICC’s Igor Puzanov, M.D., assistant professor [...]
News: Skin Cancer
Jeffrey Sosman, M.D., professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA). Sosman is among the Dream Team’s principal investigators who will work closely to write the genomic-driven clinical trials and [...]
What is Melanoma/ Skin Cancer? Melanoma is a cancer that begins in specific type of skin cell. The skin is the body’s largest organ, and it helps protect against, heat, sunlight, injury and infection. Your skin helps control body temperature as well as stores water, fat and vitamin D. With several layers, the epidermis and [...]
A new drug used to treat advanced melanoma patients with a specific genetic mutation in their tumors demonstrated significant tumor shrinkage in the majority of patients during a clinical trials.
When it comes to damaging sun rays, skin protection is a top priority for many. But there is another area that needs to be brought into focus — the eyes. Excessive exposure to ultraviolet (UV) light reflected off sand, water or pavement can damage the eyes, said Vanderbilt Eye Institute’s Mark Melson, M.D., oculoplastic and [...]